NAS:KMDA (Israel)  
Kamada Ltd logo

Kamada Ltd

$ 4.50 +0.05 (+1.12%) 10:08 PM EST
On watch
P/E:
At Loss
P/B:
1.16
Market Cap:
$ 201.87M
Enterprise V:
$ 195.08M
Volume:
79.38K
Avg Vol (2M):
31.45K
Also Trade In:
Volume:
79.38K
Market Cap $:
201.87M
PE Ratio:
At Loss
Avg Vol (2-Month):
31.45K
Enterprise Value $:
195.08M
PB Ratio:
1.16
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Name Current Vs Industry Vs History
Cash-To-Debt 1.29
Equity-to-Asset 0.56
Debt-to-Equity 0.14
Debt-to-EBITDA -17.82
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.17
Distress
Grey
Safe
Beneish M-Score 2.11
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.98
9-Day RSI 28.92
14-Day RSI 33.87
6-1 Month Momentum % -10.53
12-1 Month Momentum % -5.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.39
Quick Ratio 1.09
Cash Ratio 0.6
Days Inventory 284.83
Days Sales Outstanding 88.29
Days Payable 88.87

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.6

Financials (Next Earnings Date:2022-11-22 Est.)

KMDA's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:KMDA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 106.186
EPS (TTM) ($) -0.26
Beta 0.93
Volatility % 28.97
14-Day RSI 33.87
14-Day ATR ($) 0.164843
20-Day SMA ($) 4.80475
12-1 Month Momentum % -5.03
52-Week Range ($) 4.22 - 6.96
Shares Outstanding (Mil) 44.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Kamada Ltd Filings

Document Form Filing Date
No Filing Data

Kamada Ltd Analysis

Share your research

Headlines

See More
No news.